Welcome to the Peters Lab at UW–Madison

In the Peters Lab, we use the power of bacterial genetics to address key issues in antimicrobial resistance and the bio-economy. Our CRISPR-based functional genomics approaches allow us to define genetic targets in bacteria for therapeutic or engineering purposes. We are currently developing innovative genetic tools for systematic gene function exploration in Gram-negative ESKAPE pathogens (Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae) and alphaproteobacteria used to make valuable bio-products (Zymomonas mobilis, Rhodobacter sphaeroides, and Novosphingobium aromaticivorans).